Have a personal or library account? Click to login
Recent approaches in the drug research and development of novel antimalarial drugs with new targets Cover

Recent approaches in the drug research and development of novel antimalarial drugs with new targets

Open Access
|Jan 2023

Authors

Naveen Kumar Reddy Chinnappanna

Shri Vishnu College of Pharmacy, B.V Raju group of Institutions, India

Gopi Yennam

Shri Vishnu College of Pharmacy, B.V Raju group of Institutions, India

Chaitanya Budagam Haima Naga Venkata Chaitanya

Shri Vishnu College of Pharmacy, B.V Raju group of Institutions, India

Shinu Pottathil

Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Kingdom of Saudi Arabia

Pobitra Borah

School of Pharmacy, Graphic Era Hill University, Dehradun, India

Katharigatta N. Venugopala

katharigattav@dut.ac.za

Department of Biotechnology and Food Science Faculty of Applied Sciences, Durban University of Technology, Durban, South Africa
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia

Pran Kishore Deb

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman, Jordan

Raghu Prasad Mailavaram

raghuprasad.mailavaram@svkm.ac.in

Department of Pharmaceutical Chemistry, Shri Ville Parle Kelavani Mandal’s Institute of Pharmacy Survey No. 499
DOI: https://doi.org/10.2478/acph-2023-0001 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 1 - 27
Accepted on: Sep 16, 2022
Published on: Jan 24, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2023 Naveen Kumar Reddy Chinnappanna, Gopi Yennam, Chaitanya Budagam Haima Naga Venkata Chaitanya, Shinu Pottathil, Pobitra Borah, Katharigatta N. Venugopala, Pran Kishore Deb, Raghu Prasad Mailavaram, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.